WallStreetZenWallStreetZen

NYSE: PFE
Pfizer Inc Stock

Overview
ForecastEarningsDividendOwnershipStatistics
$54.33+0.96 (+1.8%)
Updated Jan 28, 2022
PFE Price
$54.33
Fair Value Price
N/A
Market Cap
$304.95B
52 Week Low
$33.36
52 Week High
$61.71
P/E
15.89x
P/B
4.03x
P/S
3.79x
PEG
13.2x
Dividend Yield
2.89%
Revenue
$63.60B
Earnings
$19.18B
Gross Margin
64.2%
Operating Margin
31.77%
Profit Margin
30.2%
Debt to Equity
1.36
Operating Cash Flow
$32B
Beta
0.64
Next Earnings
Feb 8, 2022
Ex-Dividend
Jan 27, 2022
Next Dividend
Mar 4, 2022

Zen Score

High
Medium
Low
–
Industry Average (42)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PFE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

PFE ($54.33) is trading below its intrinsic value of $83.41, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
PFE is good value based on its earnings relative to its share price (15.89x), compared to the US market average 33.7x)
Valuation
PFE is good value based... subscribe to Premium to read more.
Valuation
There are 34 more PFE due diligence checks available for Premium users.

PFE News

Valuation

PFE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
15.89x
Industry
25.74x
Market
33.7x
PFE is good value based... subscribe to Premium to read more.
Valuation
PFE is good value based... subscribe to Premium to read more.
Valuation

PFE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.03x
Industry
5.12x
PFE is good value based... subscribe to Premium to read more.
Valuation

PFE price to earnings growth (PEG)

For valuing profitable companies with growth potential
PFE is poor value relative... subscribe to Premium to read more.
Valuation

PFE's financial health

Profit margin

Revenue
$24.1B
Net Income
$8.1B
Profit Margin
33.8%
PFE's Earnings (EBIT) of $20.21B... subscribe to Premium to read more.
Financials
PFE's profit margin has increased... subscribe to Premium to read more.
Financials

Assets to liabilities

Assets
$179.2B
Liabilities
$103.2B
Debt to equity
1.36
PFE's short-term assets ($57.90B) exceed... subscribe to Premium to read more.
Financials
PFE's long-term liabilities ($61.42B) exceed... subscribe to Premium to read more.
Financials
PFE's debt relative to shareholder... subscribe to Premium to read more.
Financials
PFE's debt to equity ratio... subscribe to Premium to read more.
Financials

Cash flow

Operating
$10.8B
Investing
-$10.1B
Financing
-$1.1B
PFE's operating cash flow ($32.29B)... subscribe to Premium to read more.
Financials

Pfizer Stock FAQ

What is Pfizer's quote symbol?

(NYSE: PFE) Pfizer trades on the NYSE under the ticker symbol PFE. Pfizer stock quotes can also be displayed as NYSE: PFE.

What is the 52 week high and low for Pfizer (NYSE: PFE)?

(NYSE: PFE) Pfizer's 52-week high was $61.71, and its 52-week low was $33.36. It is currently -11.96% from its 52-week high and 62.86% from its 52-week low.

How much is Pfizer stock worth today?

(NYSE: PFE) Pfizer currently has 5,612,866,598 outstanding shares. With Pfizer stock trading at $54.33 per share, the total value of Pfizer stock (market capitalization) is $304.95B.

Pfizer stock was originally listed at a price of $24.85 in Dec 31, 1997. If you had invested in Pfizer stock at $24.85, your return over the last 24 years would have been 118.61%, for an annualized return of 3.31% (not including any dividends or dividend reinvestments).

How much is Pfizer's stock price per share?

(NYSE: PFE) Pfizer stock price per share is $54.33 today (as of Jan 28, 2022).

What is Pfizer's Market Cap?

(NYSE: PFE) Pfizer's market cap is $304.95B, as of Jan 29, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Pfizer's market cap is calculated by multiplying PFE's current stock price of $54.33 by PFE's total outstanding shares of 5,612,866,598.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.